Pharmaceuticals: IPM: 7% value and 2% unit decline in Jul-25
As per IQVIA, IPM saw 7.1% YoY growth in Jul-25 on a high base of 11.7% growth in Jul-24 (~11.5% YoY in Jun’25, 9% YoY in Q1FY26, and 8% in FY25)...
177 Views
HSIE Results Daily: Infosys, Dr Reddy’s Laboratories, Persistent Systems...
Infosys: Infosys delivered strong Q1FY26 performance, delivering market-leading sequential growth of 2.6% QoQ (organic ~2.2%) and 3.8% YoY in CC terms
370 Views
Pharmaceuticals: IPM: 11.5% value and 5% unit growth in Jun’25
As per IQVIA, IPM saw a strong growth for Jun’25 at 11.5% YoY (vs 7% in Apr’25 and FY25, +7% YoY in Jun’24) with 5% YoY growth in units
191 Views
Pharma and Healthcare: Q1FY26: Steady Revenues, Margins Under Pressure
he India Pharma and Healthcare sector is expected to see steady revenue growth. However, EBITDA margins are expected to show a decline for Q1FY26E
224 Views
Q1FY26 Earnings Preview - Pharma and Healthcare
We anticipate that pharmaceutical companies within our coverage will collectively demonstrate revenue growth of 9.9% YoY and 0.8% QoQ, along with...
164 Views